Home > Insider Trading > Filing (0001181431-14-008360)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367920	Concert Pharmaceuticals Inc.	CNCE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1028348	Brookside Capital Partners Fund Lp	John Hancock Tower, 200 Clarendon Street Boston MA 02116	No	No	Yes	No
1056548	P L Investors Capital Brookside	John Hancock Tower, 200 Clarendon Street Boston MA 02116	No	No	Yes	No
1156175	Brookside Capital Management Llc	John Hancock Tower, 200 Clarendon Street Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-19	761,062	$0.00	793,851	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-02-19	353,982	$0.00	1,147,833	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-02-19	350,000	$14.00	1,497,833	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	SERIES B CONVERTIBLE PREFERRED STOCK	Disposition	2014-02-19	4,300,000	$0.00	761,062	$0.00
Common Stock	SERIES C CONVERTIBLE PREFERRED STOCK	Disposition	2014-02-19	2,000,000	$0.00	353,982	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

The Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-5.65 basis upon the closing of the Issuer's initial public offering without payment of consideration.
Brookside Capital Management, LLC ("BCM") is the sole general partner of Brookside Capital Investors, L.P. ("BCI"). BCI is the sole general partner of Brookside Capital Partners Fund, L.P. ("BCPF"). BCM and BCI each may be deemed to share voting dispositive powers with respect to the shares held by BCPF. Each of BCM and BCI disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.
Not applicable.